Tele-Electrocardiography in Emergency Cardiac Care
|ClinicalTrials.gov Identifier: NCT00075088|
Recruitment Status : Completed
First Posted : January 5, 2004
Results First Posted : August 19, 2013
Last Update Posted : June 17, 2015
|Condition or disease||Intervention/treatment||Phase|
|Myocardial Infarction Chest Pain||Device: Electrocardiogram (ECG) Intervention Other: Routine Clinical Practice||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||794 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Tele-electrocardiography in Emergency Cardiac Care|
|Study Start Date :||September 2003|
|Primary Completion Date :||June 2009|
|Study Completion Date :||June 2009|
Experimental: Electrocardiogram (ECG) Intervention
Patients randomized to the experimental group had their ECGs printed out in the target ED with an audible voice alarm. Print-out of the pre-hospital ECG in the target ED was the intervention.
Device: Electrocardiogram (ECG) Intervention
Pre-hospital electrocardiographic (ECG) monitoring with special software to detect myocardial ischemia and to automatically transmit an ECG to the destination hospital emergency department with a voice alarm announcing "Incoming ECG from the field" and print out in the ED.
Routine Clinical Practice
Control patients had an ECG conducted after hospital arrival, as was the standard of care in the county.
Other: Routine Clinical Practice
ECG in the ED as part of routine clinical practice.
- Hospital Time to Treatment for Patients With Unstable Angina/Non-STEMI [ Time Frame: Day 1 ]Time from ED arrival to first drug was determined as recommended by American College of Cardiology/American Heart Association 2007 guidelines for management of patients with unstable angina/non-STEMI
- Hospital Time to Treatment for Patients With ST-elevation Myocardial Infarction (STEMI) [ Time Frame: Day 1 ]Mean door-to-balloon time
- Rehospitalization and Mortality [ Time Frame: 4 years ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00075088
|United States, California|
|University of California San Francisco|
|San Francisco, California, United States, 94143|
|Principal Investigator:||Barbara J Drew, RN PhD FAAN||University of California, San Francisco|